BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30039745)

  • 21. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.
    Kuusisto J; Koivisto K; Kervinen K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Pyörälä K; Kesäniemi YA; Riekkinen P
    BMJ; 1994 Sep; 309(6955):636-8. PubMed ID: 8086986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease.
    Hao X; Yao X; Yan J; Risacher SL; Saykin AJ; Zhang D; Shen L;
    Neuroinformatics; 2016 Oct; 14(4):439-52. PubMed ID: 27277494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
    J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
    Pardo JV; Lee JT;
    eNeuro; 2018; 5(1):. PubMed ID: 29497704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's disease.
    Lee SA; Sposato LA; Hachinski V; Cipriano LE
    Alzheimers Res Ther; 2017 Mar; 9(1):18. PubMed ID: 28302164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
    O'Meara ES; Kukull WA; Sheppard L; Bowen JD; McCormick WC; Teri L; Pfanschmidt M; Thompson JD; Schellenberg GD; Larson EB
    Am J Epidemiol; 1997 Sep; 146(5):373-84. PubMed ID: 9290497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multi-state model in the evaluation of outcome on mild cognitive impairment to Alzheimer's disease].
    Gao JW; Yang SS; Zhou LY; Wang XC; Gao CH; Song PP; Yu HM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 May; 33(5):470-3. PubMed ID: 22883171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Diagnostic Accuracy of Alzheimer's Disease by Combining Regional Cortical Thickness and Default Mode Network Functional Connectivity: Validated in the Alzheimer's Disease Neuroimaging Initiative Set.
    Park JE; Park B; Kim SJ; Kim HS; Choi CG; Jung SC; Oh JY; Lee JH; Roh JH; Shim WH;
    Korean J Radiol; 2017; 18(6):983-991. PubMed ID: 29089831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database.
    Ito K; Corrigan B; Zhao Q; French J; Miller R; Soares H; Katz E; Nicholas T; Billing B; Anziano R; Fullerton T;
    Alzheimers Dement; 2011 Mar; 7(2):151-60. PubMed ID: 20810324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.
    Lin AL; Jahrling JB; Zhang W; DeRosa N; Bakshi V; Romero P; Galvan V; Richardson A
    J Cereb Blood Flow Metab; 2017 Jan; 37(1):217-226. PubMed ID: 26721390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies.
    Lehtovirta M; Laakso MP; Frisoni GB; Soininen H
    Neurobiol Aging; 2000; 21(2):293-300. PubMed ID: 10867214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    Ardekani BA; Bermudez E; Mubeen AM; Bachman AH;
    J Alzheimers Dis; 2017; 55(1):269-281. PubMed ID: 27662309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
    Platero C; Lin L; Tobar MC
    Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
    Chételat G; Fouquet M
    Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data.
    Kong D; Giovanello KS; Wang Y; Lin W; Lee E; Fan Y; Murali Doraiswamy P; Zhu H
    J Alzheimers Dis; 2015; 46(3):695-702. PubMed ID: 25869783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Structural Parametrization of the Brain Using Hidden Markov Models-Based Paths in Alzheimer's Disease.
    Martinez-Murcia FJ; Górriz JM; Ramírez J; Ortiz A
    Int J Neural Syst; 2016 Nov; 26(7):1650024. PubMed ID: 27354189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.